Albert Bourla

Pfizer Inc. (NYSE: PFE) shares rose to a 52-week high of $41.99 Monday thanks to strong late-stage interim readout for the mRNA vaccine candidate BNT162b2 the company is co-developing with its German partner BioNTech SE – ADR (NASDAQ: BNTX). Some insider stock sales at the company are...

Monday could go down in the history books as "a great day for humanity" after Pfizer Inc. (NYSE: PFE) released encouraging results from its COVID-19 vaccine study, Pfizer CEO Albert Bourla said on CNBC's "Squawk Box." Pfizer's 'Overwhelming' Data: Pfizer's...

Pfizer Inc (NYSE: PFE) CEO Albert Bourla decried the politicization of the COVID-19 vaccine in an internal memo on Thursday, CNBC reported. What Happened: Bourla expressed his disappointment over the first presidential debate between President Donald Trump and former Vice President Joe...

Major coronavirus treatments and vaccine maker executives were interviewed on CNBC Monday to discuss their company's progress in the battle against the disease. Gilead CEO On Remdesivir: Gilead Sciences, Inc.'s (NASDAQ: GILD) remdesivir received an emergency use authorization designation in...

Pfizer Inc. (NYSE: PFE) wouldn't give a discount to any developed country for its novel coronavirus (COVID-19) vaccine — over the price it's charging the United States under a contract signed last week — CEO Albert Bourla said at a conference call Tuesday. What Happened: "...

The 35th JPMorgan Chase & Co. (NYSE: JPM) Healthcare Conference gets underway on January 9 and will go on until January 13. Touted as the life science industry's largest conferences of the year, the event showcases innovations of healthcare companies, which are out to scout for their next...